Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - OTHER CURRENT ASSETS
Other Current Assets KALV - KalVista Pharmaceuticals, Inc.
4.42 M
LAST VALUE
-35.56%
2 YEAR CAGR
5.25%
5 YEAR CAGR
42.38%
10 YEAR CAGR